🧪
hypothesis

Small-Molecule Modulation of TDP-43 Liquid-Liquid Phase Separation for ALS/FTD

Hypothesis

Small-Molecule Modulation of TDP-43 Liquid-Liquid Phase Separation for ALS/FTD

High-throughput screening for compounds that restore proper TDP-43 granule dynamics by preventing pathological liquid-to-solid phase transitions, maintaining nuclear function.
🧬 TARDBP🩺 neurodegeneration🎯 Composite 56%💱 $0.54▼2.7%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 3 support✗ 3 oppose
✓ All Quality Gates Passed
Mechanistic 0.55 (15%) Evidence 0.50 (15%) Novelty 0.85 (12%) Feasibility 0.40 (12%) Impact 0.75 (12%) Druggability 0.35 (10%) Safety 0.50 (8%) Competition 0.70 (6%) Data Avail. 0.60 (5%) Reproducible 0.45 (5%) KG Connect 0.50 (8%) 0.565 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite56%

🧪 Overview

High-throughput screening for compounds that restore proper TDP-43 granule dynamics by preventing pathological liquid-to-solid phase transitions, maintaining nuclear function. Highly novel but technically immature with no validated LLPS-modulating pharmacophores or clinical biomarkers.

🧬 Mechanism

No curated mechanism pathway recorded for this hypothesis.

⚖️ Evidence

⚖️ Evidence Matrix3 supports3 contradicts
Supports
TDP-43 undergoes liquid-liquid phase separation in vitro forming dynamic condensates
PMID:31291956
Supports
Phosphorylation alters TDP-43 condensation properties affecting phase transition dynamics
PMID:34294921
Supports
Nuclear TDP-43 loss drives cytoplasmic aggregation in frontotemporal lobar degeneration
PMID:29590636
Contradicts
Distinguishing pathological versus physiological LLPS technically challenging—modulators may disrupt both states
Contradicts
No direct evidence that small molecules can revert solid aggregates to benign liquid droplets in cellular or animal models
Contradicts
High-throughput LLPS screens face reproducibility challenges—liquid-to-solid transitions difficult to measure robustly
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — TARDBP

🧬 PDB 4BS2 Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for TARDBP →

No DepMap CRISPR Chronos data found for TARDBP.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
↔
Stable
7d Momentum
▼ 0.0%
Volatility
Low
0.0027
Events (7d)
3
Price History
▼2.7%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

View on SciDEX ↗